Gwen Hyland

In rare disease, every patient matters—and every message carries weight. Traditional marketing models fall short when audiences are small, diagnosis journeys are long, and awareness is often limited across both patients and healthcare providers. This dynamic panel will explore how leading teams are reimagining engagement in rare disease: from finding the “needle in the haystack” through advanced segmentation and AI, to crafting deeply personal content that builds trust and community. Panelists will dive into real-world challenges, including cross-functional alignment with advocacy and medical affairs, navigating regulatory complexities, and ensuring that campaigns are not only compliant—but compassionate. Attendees will walk away with insights on how to elevate their brand strategy in the most human-centered corner of healthcare marketing